Merck KGaA Prepares to Delist AZ Electronic Materials

With 97% of all shares in AZ Electronic Materials in hand, Germany's Merck KGaA has moved closer to its goal of delisting the company.

The German chemicals and pharmaceuticals producer closed the €2 billion acquisition on May 9 after receiving the green light from Chinese antitrust authorities.

Merck extended its offer seven times and during the process reduced its initial minimal acceptance threshold to 75% from 95%.

AZ, once part of the now defunct German chemical group Hoechst, produces chemicals for integrated circuits.

Merck said it will now "swiftly start" the integration of the acquired company, which employs around 1,150 people worldwide, and expects all major measures to be completed by the end of 2014. AZ's former CEO, Geoff Wild, will remain with the company to support a smooth integration into Merck's Performance Materials division.

During the integration, it will be operated as a separate business unit alongside Merck's three existing business units Liquid Crystals, Pigments & Cosmetics and Advanced.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read